الفهرس 
coverOnly 14 pages are availabe for public view
 |  | from | 187 |  |  |
| | | from | 187 | | |
Abstract
Infection with HCV is the most common liver
disease in HD patients, while liver disease is a significant
cause of morbidity in patients with end stage renal disease
treated by dialysis or transplantation.
The prevalence of hepatitis C virus (HCV) infection
is estimated to be 3% worldwide, Egypt has the largest epidemic of hepatitis C virus (HCV) in the world with
14.7% of the population are infected with HCV.
The prevalence of anti-HCV positivity among dialysis
patients varies in different countries (5%-85% worldwide),
but may exceed 95% in some HD units.Unfortunately
Egypt also is considered one of the countries with the
highest prevalance
This work is a part of project aiming to survey about
HCV among HD patients, assessing its prevalence,
seroconversion and study risk factors associated with HCV
seroconversion among hemodialysis patients in Egypt. This
project is modulated by the nephrology department, Ain
Shams University.